UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 17, 2018

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

1-10879

22-2785165

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

358 Hall Avenue, Wallingford, Connecticut

 

06492

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (203) 265-8900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 



 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The annual meeting of stockholders of the Company was held on May 17, 2018.  As of March 19, 2018, the record date for the meeting, 302,001,190 shares of the Company’s Class A Common Stock were outstanding.  A quorum of 279,147,813 shares were present or represented at the meeting.

 

The stockholders (i) elected each of the Company’s nominees for director; (ii) ratified the selection of Deloitte & Touche LLP as independent accountants of the Company; (iii) approved the advisory vote on compensation of named executive officers;   and (iv) voted against a stockholder proposal for special shareholder meeting improvement. Voting of shares for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 13, 2018, is as follows:

 

1.              Election of Directors

 

 

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-votes

 

Ronald P. Badie

 

259,209,376

 

11,831,012

 

197,280

 

7,910,145

 

Stanley L. Clark

 

258,830,795

 

12,210,077

 

196,796

 

7,910,145

 

John D. Craig

 

269,726,082

 

1,350,234

 

161,352

 

7,910,145

 

David P. Falck

 

266,566,623

 

4,509,461

 

161,584

 

7,910,145

 

Edward G. Jepsen

 

258,581,816

 

12,477,619

 

178,233

 

7,910,145

 

Martin H. Loeffler

 

261,894,703

 

8,901,113

 

441,852

 

7,910,145

 

John R. Lord

 

257,454,407

 

13,585,883

 

197,378

 

7,910,145

 

R. Adam Norwitt

 

266,340,091

 

4,755,130

 

142,447

 

7,910,145

 

Diana G. Reardon

 

262,892,201

 

8,211,322

 

134,145

 

7,910,145

 

Anne Clarke Wolff

 

269,766,313

 

1,318,340

 

153,015

 

7,910,145

 

 

2.              Ratification of Selection of Deloitte & Touch LLP as Independent Accountants of the Company

 

Votes For:

 

272,881,996

 

Votes Against:

 

6,144,241

 

Abstentions:

 

121,576

 

Broker Non-Votes:

 

0

 

 

3.              Advisory Vote on Compensation of Named Executive Officers:

 

Votes For:

 

254,898,686

 

Votes Against:

 

16,107,500

 

Abstentions:

 

231,482

 

Broker Non-Votes:

 

7,910,145

 

 

4.              Stockholder Proposal for Special Shareholder Meeting Improvement:

 

Votes For:

 

99,608,524

 

Votes Against:

 

171,277,751

 

Abstentions:

 

351,393

 

Broker Non-Votes:

 

7,910,145

 

 

2



 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

AMPHENOL CORPORATION

 

 

 

 

By:

/s/ R. Adam Norwitt

 

 

R. Adam Norwitt

 

 

President and Chief Executive Officer

 

 

 

Date: May 18, 2018

 

 

 

3